Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Long-Term Debt Repayments (2018 - 2020)

Anaptysbio's Long-Term Debt Repayments history spans 3 years, with the latest figure at $1.4 million for Q1 2020.

  • For Q1 2020, Long-Term Debt Repayments fell 26.67% year-over-year to $1.4 million; the TTM value through Dec 2020 reached $1.4 million, down 81.67%, while the annual FY2020 figure was $1.4 million, 81.67% down from the prior year.
  • Long-Term Debt Repayments reached $1.4 million in Q1 2020 per ANAB's latest filing, down from $1.9 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $1.9 million in Q2 2018 to a low of $1.2 million in Q1 2018.
  • Average Long-Term Debt Repayments over 3 years is $1.8 million, with a median of $1.9 million recorded in 2018.
  • Peak YoY movement for Long-Term Debt Repayments: surged 50.0% in 2019, then fell 26.67% in 2020.
  • A 3-year view of Long-Term Debt Repayments shows it stood at $1.9 million in 2018, then changed by 0.0% to $1.9 million in 2019, then decreased by 26.67% to $1.4 million in 2020.
  • Per Business Quant, the three most recent readings for ANAB's Long-Term Debt Repayments are $1.4 million (Q1 2020), $1.9 million (Q4 2019), and $1.9 million (Q3 2019).